KCT0004476已完成未知
Clinical utility of [F-18]PSMA-1007 PET/CT (positron emission tomography/computed tomography) in evaluating preoperative staging of prostate cancer before radical prostatectomy
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 126
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20?(Year) 至 0No Limit（—）
- 性别
- Male
入选标准
- •1. Inclusion Criteria
- •(1) An adult male aged 20 years or older who is planning to undergo radical prostatectomy for intermediate to high risk prostate cancer.
- •(2) The subject can and will follow the clinical trial procedure, and the subject obtains a signed and dated patient consent.
排除标准
- •2. Exclusion Criteria
- •(1) Patients who do not agree with the study
- •(2) Patients with hypersensitivity to radioisotopes
- •(3) Participants in other studies at the time of screening who may influence [F-18] PSMA-1007 image acquisition.
- •(4) A person deemed difficult to conduct a clinical trial due to a serious medical condition by the researcher.
- •(5) Those who have had a mental illness that is difficult to scan PET/CT.
- •(6) Vulnerable subjects (researchers or students involved in the research, researchers or students of the researchers involved in the research, the family of the subjects)
- •(7) Other investigator determined to be unsuitable for participation in this clinical trial
- •(8) Those who were found to be difficult to remove surgically on the areas that appeared positive on PET imaging.
研究者
相似试验
已完成
3 期
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerProstate Cancer RecurrentProstate CancerNCT04742361ABX advanced biochemical compounds GmbH136
招募中
不适用
Evaluation of the use of PET/CT in Adenoid Cystic Carcinoma (ADC)Adenoid Cystic CarcinomaRBR-84nmnm9Eduardo Nóbrega Pereira Lima
尚未招募
不适用
Prostate Cancer 18F-PSMA-1007 PET/CT Access TrialProstate CancerNCT06489496Alberta Health services1,000
招募中
3 期
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate CancerProstate CancerNCT06122584ABX advanced biochemical compounds GmbH380
进行中（未招募）
1 期
PSMA vs FACBC compared to PLND for lymph node staging in primary prostate cancerProstate cancer (PCa) is the most common malignancy amongst men in Westerncountries. In order to select the most suitable treatment for patients diagnosed with PCa, it is importantto stage accurately. Both 18F-PSMA-1007 PET/CT and anti-3-[18F] FACBC PET/CT are currently mostly used to detectrecurrence in treated PCa, while the diagnostic value in detecting lymph node metastasis in primaryprostate cancer is not yet clear.EUCTR2019-004045-33-NLCatharina Hospital Eindhoven70